Are states actually joining Trump’s Medicaid drug pricing initiative yet?

Not clearly. While Trump officials said every state wanted to participate, the report says several states were still unsure, which weakens the claim of broad buy-in. That means the initiative’s real impact on drug pricing remains uncertain until states formally opt in and define how they would implement it.